Clinical application of 18F-DOPA PET/TC in pediatric patients

the use 18F-DOPA PET/CT for oncologic and non-oncologic pediatric diseases is well consolidated in clinical practice. the indications include brain tumors, neuroendocrine malignancies and congenital hyperinsulinism. the number of papers involving pediatric subjects is steadily growing. however, literature still lacks clinical trials and large multicentric studies in contrast with the extensive literature available for adult patients. the aim of this review is to discuss the main clinical indications of 18F-DOPA in pediatric oncologic and nononcologic diseases and to analyze its role in diagnosis, staging, biopsy and surgical planning. the high resolution of PET/CT tomographs in addition to the high sensitivity and specificity of 18F-DOPA imaging exceeds the downsides linked to this nuclear medicine imaging modality. In fact, few potential limitations could discourage the use of PET/CT imaging. for example, similarly to MRI studies the long acquisition time of a PET/CT scan often requires sedation especially in infants. moreover, the radiation exposure of a PET/CT scan may be high, but the clinical benefit deriving from nuclear medicine imaging outruns the risk connected to the use of ionizing radiations.